Same Indication

Trastuzumab vs Zavegepant

## Trastuzumab vs Zavegepant: Overview

This comparison examines the pharmacological differences between **Trastuzumab** and **Zavegepant**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Trastuzumab — 28 days; Zavegepant — N/A.

## Chemical Properties

**Type**: Trastuzumab — Antibody; Zavegepant — Small molecule.